Status:
UNKNOWN
Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults
Lead Sponsor:
University of Dublin, Trinity College
Collaborating Sponsors:
Actial Farmaceutica S.r.l.
Conditions:
Alteration of Cognitive Function
Disturbance in Affect (Finding)
Eligibility:
All Genders
65-75 years
Phase:
NA
Brief Summary
This research aims to determine whether a 12 week daily dose of VSL#3 has any measurable effects on memory, attention, executive function or self-reported mood and anxiety in healthy older adults.
Detailed Description
This research aims to investigate the effect of dietary supplement VSL#3 on memory, attention, executive function and mood in healthy older adults. The study will be a randomised double-blind placebo...
Eligibility Criteria
Inclusion
- Aged between 65 and 75
- MMSE score \> 23
- Willingness to give informed consent
- Commitment to take the VSL#3 supplement daily for 12 weeks
- Alcohol consumption less than 21 units per week (men), 14 units per week (women)
Exclusion
- Current psychoactive medication
- Significant active medical conditions
- History of major psychiatric or neurological condition
- Smoker
- History of epilepsy
- History of traumatic brain injury
- History of immunodeficiency
- Taking immunosuppressants or corticosteroids
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01877967
Start Date
May 1 2013
End Date
July 1 2015
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Neuroscience, Trinity College, Dublin
Dublin, Co. Dublin, Ireland, 0000